Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
dietary supplement |
| gptkbp:administeredBy |
oral route
intravenous route |
| gptkbp:ATCCode |
N06BX12
|
| gptkbp:CASNumber |
5080-50-2
|
| gptkbp:category |
antioxidant
dietary supplement nutraceutical estrogen neuroprotective agent zwitterion amino acid derivative quaternary ammonium compound nootropic acetate ester carnitine ester cholinergic mitochondrial function modulator |
| gptkbp:chemicalFormula |
C9H17NO4
|
| gptkbp:foundIn |
human body
|
| gptkbp:hasRole |
mitochondrial energy metabolism
acetyl group donor fatty acid transport |
| gptkbp:hasUNII |
6DH1W9VH8Q
|
| https://www.w3.org/2000/01/rdf-schema#label |
acetylcarnitine
|
| gptkbp:IUPACName |
(R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate
|
| gptkbp:KEGGID |
C02571
|
| gptkbp:meltingPoint |
197–198 °C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
203.24 g/mol
|
| gptkbp:otherName |
gptkb:ALCAR
L-acetylcarnitine |
| gptkbp:predecessor |
gptkb:carnitine
|
| gptkbp:PubChem_CID |
CHEMBL1201272
CHEBI:15355 65546 DB08842 |
| gptkbp:relatedTo |
gptkb:carnitine
L-carnitine propionyl-L-carnitine |
| gptkbp:sideEffect |
nausea
headache restlessness insomnia increased appetite |
| gptkbp:solubility |
soluble
|
| gptkbp:usedFor |
dietary supplement
treatment of depression nootropic treatment of Alzheimer's disease treatment of neuropathic pain |
| gptkbp:bfsParent |
gptkb:carnitine
gptkb:OCTN2_transporter gptkb:carnitine_transporter_2 |
| gptkbp:bfsLayer |
8
|